SUPERSEDED Local Coverage Determination (LCD)

Non-Invasive Peripheral Venous Studies

L35451

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.
Superseded
To see the currently-in-effect version of this document, go to the section.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L35451
Original ICD-9 LCD ID
Not Applicable
LCD Title
Non-Invasive Peripheral Venous Studies
Proposed LCD in Comment Period
N/A
Source Proposed LCD
DL35451
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 12/17/2020
Revision Ending Date
01/27/2024
Retirement Date
N/A
Notice Period Start Date
10/13/2016
Notice Period End Date
11/30/2016

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description
Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

This LCD supplements but does not replace, modify or supersede existing Medicare applicable National Coverage Determinations (NCDs) or payment policy rules and regulations for non-invasive peripheral venous studies. Federal statute and subsequent Medicare regulations regarding provision and payment for medical services are lengthy. They are not repeated in this LCD. Neither Medicare payment policy rules nor this LCD replace, modify or supersede applicable state statutes regarding medical practice or other health practice professions acts, definitions and/or scopes of practice. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations and rules for Medicare payment for non-invasive peripheral venous studies and must properly submit only valid claims for them. Please review and understand them and apply the medical necessity provisions in the policy within the context of the manual rules. Relevant CMS manual instructions and policies may be found in the following Internet-Only Manuals (IOMs) published on the CMS Web site:

IOM Citations:

  • CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80 - Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests
  • CMS IOM Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, 
    • Part 1, Section 20.14 - Plethysmography
    • Part 4, Section 220.5 - Ultrasound Diagnostic Procedures 
  • CMS IOM Publication 100-04, Medicare Claims Processing Manual
    • Chapter 13 - Radiology Services and Other Diagnostic Procedures, Section 10 - ICD Coding for Diagnostic Tests and Section 20 - Payment Conditions for Radiology Services
  • CMS IOM Publication 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.4 Reasonable and Necessary Provisions in LCDs

Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.
  • Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.


History/Background and/or General Information

Non-invasive vascular diagnostic studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in the venous system. “Vascular studies include patient care required to perform the studies, supervision of the studies and interpretation of study results with copies for patient records of hard copy output with analysis of all data, including bidirectional vascular flow or imaging when provided.” (AMA 2018 CPT book, page 654). A hard copy, or a soft copy convertible to a hard copy, provides a permanent record of the study performed and must be of a quality that meets accepted radiologic standards.

A duplex scan combines Doppler spectrum analysis and conventional ultrasound, to visualize the structure of blood vessels, how the blood is flowing through the vessels, and whether there is any obstruction in the vessels.

A non-invasive physiologic study implies functional measurement procedures including Doppler waveform analysis, blood pressure measurements, or plethysmography.

Plethysmography implies volume measurement procedures including air, impedance, or strain gauge methods.


Covered Indications

1. Deep Vein Thrombosis (DVT)

Due to the risk of DVT associated with pulmonary embolism (PE), objective testing of venous function is considered reasonable and necessary in patients that are candidates for anticoagulation or invasive therapeutic procedures for any one of the following:

  • To evaluate clinical signs or symptoms suggestive of acute or new onset DVT such as extremity swelling, tenderness, inflammation or erythema.
  • Investigation for DVT as the source of a suspected or confirmed pulmonary embolism.
  • Evaluation of unexplained extremity edema, especially unilateral or asymmetric, in an individual at risk for DVT (e.g., immobile, status-post major surgical procedure, indwelling vascular catheter or prosthesis, or postpartum). Bilateral or symmetric limb edema is more likely to result from a systemic disorder (e.g., congestive heart failure, hypoalbuminemia, arthritis) or certain drugs. Therefore, bilateral limb edema is considered reasonable and necessary for venous studies in individuals at risk for DVT when there is no otherwise plausible cause.
  • Follow-up for patients with known venous thrombosis to monitor for progression, determine course of treatment or the need to alter treatment based on new symptoms.


2. Chronic Venous Insufficiency

Chronic venous insufficiency is impaired venous return which may cause lower extremity symptoms. Objective testing of venous function is considered reasonable and necessary in patients that are candidates for anticoagulation or invasive therapeutic procedures for any one of the following:

  • Evaluation of Postthrombotic (Postphlebitic) Syndrome (PTS) in patients with symptoms of PTS (e.g., chronic leg pain, leg heaviness, leg swelling, leg itching or ulcers on the leg).
  • Evaluation of suspected valvular incompetence in patients with symptomatic chronic venous insufficiency or symptomatic varicose veins (e.g., significant pain or edema of the lower leg, ulceration, thickening and discoloration) suspected to be secondary to venous insufficiency in order to confirm this diagnosis prior to treatment.
  • Post-procedural assessment of venous ablation. If a great or small saphenous vein undergoes ablation, a duplex scan of the affected side is considered reasonable and necessary postoperatively within 72 hours after the procedure, to assess the result of the surgery and the possibility of propagation of a thrombus.

Please see the companion article Billing and Coding: Non-Invasive Peripheral Venous Studies, A52993, for ICD-10-CM code(s) to describe a limited venous duplex performed within 72 hours of a saphenous vein ablation procedure.

Note: Additional coverage information pertinent to the treatment of varicose veins and ablation therapy is located in LCD L34924, Treatment of Chronic Venous Insufficiency of the Lower Extremities.


3. Preoperative Examinations

Non-Invasive Peripheral Venous Studies are considered reasonable and necessary for select preoperative examinations that meet criteria for coverage as follows:

  • Bypass surgery - Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study is indicated for the preoperative examination of potential harvest vein grafts to be utilized during bypass surgery. This service is considered reasonable and necessary when the results of the study are needed to locate suitable graft vessels. The need for bypass surgery must be determined prior to performance of the test.
  • Hemodialysis access surgery - Vessel mapping for hemodialysis is indicated for the preoperative examination of vessels prior to hemodialysis access site surgery in patients with end stage renal disease (ESRD). This service is considered reasonable and necessary when the results of the study are needed to determine appropriate vessel utilization (i.e., when the patient’s clinical evaluation does not readily lead to the selection of a vein that is suitable for creating a dialysis fistula). The need for a hemodialysis access site must be determined prior to performance of the test.


Limitations

1. Objective testing of peripheral venous function is considered not reasonable and necessary and therefore non-covered for any one of the following:

    • Asymptomatic varicose veins
    • Routine screening tests

Note: Please see the billing and coding article for Non-Invasive Peripheral Venous Studies, A52993, for appropriate ICD-10-CM diagnosis code(s) used to indicate screening tests performed in the absence of a specific sign, symptom, or complaint. Screening tests performed in the absence of a specific sign, symptom, or complaint will result in the denial of claims as non-covered screening services.

2. Non-invasive vascular studies are considered not reasonable and necessary if the results are not needed for clinical decision making. If the study results will have no impact on the decision for further diagnostic or therapeutic procedures or will not provide any unique diagnostic information that would impact patient management, then the non-invasive studies are not reasonable and necessary. For example, if it is evident from the findings of the history and physical examination that the patient is going to proceed to angiography, then non-invasive vascular studies are not reasonable and necessary.

3. The following limitations apply to multiple non-invasive studies on the same encounter or same day:

    • Performance of both non-invasive extracranial arterial studies and non-invasive evaluation of extremity veins during the same encounter is rarely medically necessary. Documentation must clearly support the medical necessity if both procedures are performed during the same encounter, and be made available upon request.
    • Because signs and symptoms of arterial occlusive disease and venous disease are so divergent, the performance of simultaneous arterial and venous studies during the same encounter is rarely medically necessary. Consequently, documentation must clearly support the medical necessity of both procedures if performed during the same encounter, and be made available upon request.
    • It is rarely medically necessary to perform lower extremity and upper extremity studies on the same day. Documentation must clearly support the medical necessity of both upper and lower extremities if performed on the same day, and be made available upon request.


4. "The use of a simple hand-held or other Doppler device that does not produce hard copy data or that produces a record that does not permit analysis of bidirectional vascular flow, is considered to be part of the physical examination of the vascular system and is not separately reported.” (AMA 2018 CPT Book, Page 654) Doppler procedures performed with zero-crossers (i.e., analog [strip chart recorder] analysis) are also included in any other E/M service. Therefore, it is not reasonable and necessary to report these procedures as separate services.

5. Please refer to NCD 20.14, for a list of plethysmorgraphy methods that are not covered.


Training Requirements/Certifications

The accuracy of non-invasive diagnostic testing studies depends on the knowledge, skill and experience of the physician and/or technologist performing and interpreting the study. Documentation of applicable training and experience must be maintained and made available upon request. Services will be considered reasonable and necessary only if performed by appropriately trained personnel. Please see CMS IOM Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80, for supervision definitions and requirements for diagnostic tests.

All non-invasive vascular studies must be:

  1. Performed by a qualified physician; or
  2. Performed under the general supervision of a qualified physician by a licensed* technologist who is certified in vascular technology; or
  3. Performed in an accredited vascular laboratory.

*State licensure for a technologist is required in addition to appropriate recognized certification. Documentation of current, active licensure must be maintained and made available upon request. In the absence of a state/federal district licensing board, the requirement for licensure is waived.

A qualified physician for this service/procedure is defined as:

  1. Physician is properly enrolled in Medicare; and
  2. Training and expertise must have been acquired within the framework of an accredited residency and/or fellowship program in the applicable specialty/subspecialty in the United States or must reflect equivalent education, training, and expertise endorsed by an academic institution in the United States and/or by the applicable specialty/subspecialty society in the United States.


Appropriate technologist certification is limited to American Registry of Diagnostic Medical Sonographers (ARDMS) certification as a Registered Vascular Technologist (RVT), Cardiovascular Credentialing International (CCI) certification as a Registered Vascular Specialist (RVS) or Registered Phlebology Sonographer (RPhS), and the American Registry of Radiologic Technologists (ARRT) certification in Vascular Sonography (VS). Appropriate laboratory accreditation is limited to the American College of Radiology (ACR) Vascular Ultrasound Program, and the Intersocietal Accreditation Commission (IAC) division of Vascular Testing.

The contractor does not establish a credentialing service but the contractor is authorized to determine which organizations it recognizes. For example, the use of the word “national” in the organization’s name does not, in itself, meet Medicare standards for national credentialing.

Note: For services performed in an Independent Diagnostic Testing Facility (IDTF), please refer to Local Coverage Determination (LCD) L35448, Independent Diagnostic Testing Facility (IDTF), and related Local Coverage Article A53252, Independent Diagnostic Testing Facility (IDTF), for additional information.

This LCD imposes frequency limitations. For frequency limitations please refer to the Utilization Guidelines section below.

Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
View Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information


Refer to the Local Coverage Article: Billing and Coding: Non-Invasive Peripheral Venous Studies, A52993, for all coding information.

Documentation Requirements

  1. All documentation must be maintained in the patient’s medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The medical record documentation must support the medical necessity of the services as stated in this policy.
  4. The medical necessity for performing both non-invasive extracranial arterial studies and non-invasive evaluation of extremity veins during the same encounter must be clearly documented in the medical record.
  5. The medical necessity for performing simultaneous arterial and venous studies during the same encounter must be clearly documented in the medical record.
  6. The medical necessity of performing lower extremity and upper extremity studies on the same day must be clearly documented in the medical record.


Utilization Guidelines
In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice.

  • Only one preoperative limited scan is considered reasonable and necessary for bypass surgery.
  • Only one preoperative vessel mapping for hemodialysis access scan is considered reasonable and necessary per hemodialysis access site surgery.
  • Only one limited study is considered reasonable and necessary post operatively within 72 hours of a saphenous vein ablation, whether surgery is performed on one side or bilaterally.
  • One Doppler ultrasound study or duplex scan will be covered for documentation of disease and mapping for chronic venous insufficiency or symptomatic varicose veins.


Notice: This LCD imposes utilization guideline limitations. Despite Medicare allowing up to these maximums, each patient’s condition and response to treatment must medically warrant the number of services reported for payment. Medicare requires the medical necessity for each service reported to be clearly demonstrated in the patient’s medical record. Medicare expects that patients will not routinely require the maximum allowable number of services.

Sources of Information

Contractor is not responsible for the continued viability of websites listed.

Other Contractor Policies

L33693, Non-Invasive Evaluation of Extremity Veins, First Coast Service Options Jurisdiction N Local Coverage Determination

L34229, Noninvasive Peripheral Venous Studies, Noridian Healthcare Solutions Jurisdiction E Local Coverage Determination

L33627, Non-Invasive Vascular Studies, National Government Services Jurisdiction K Local Coverage Determination

Contractor Medical Directors

Bibliography

ACR-AIUM-SPR-SRU Practice Parameter for the Performance of Peripheral Venous Ultrasound Examination. American College of Radiology. Revised 2015 (Resolution 33).

Douketis JD. Chronic Venous Insufficiency and Postphlebitic Syndrome. Merck Manual professional version online last revised May 2014: http://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/chronic-venous-insufficiency-and-postphlebitic-syndrome.

Eskandari MK, Pearce WH, Yao J. Current Vascular Surgery 2012. Shelton, CT: People’s Medical Publishing House – USA, 2013. Accessed online on August 18, 2016.

Harlander-Locke M, Jimenez JC, Lawrence PF, et al. Management of endovenous heat-induced thrombus using a classification system and treatment algorithm following segmental thermal ablation of the small saphenous vein. Journal of Vascular Surgery, August 2013;58(2):427-432.

Khilnani NM, Grassi CJ, Kundu S, et al. Multi-society Consensus Quality Improvement Guidelines for the Treatment of Lower-extremity Superficial Venous Insufficiency with Endovenous Thermal Ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phebology , and Canadian Interventional Radiology Association. J Vasc Interv Radiol 2010;21:14-31.

Lawrence, Peter F et al, Classification of proximal endovenous closure levels and treatment algorithm. Journal of Vascular Surgery. August 2010, Vol 52 (2):388-393.

Luckraz H, Lowe J, Pugh N, et al. Pre-operative long saphenous vein mapping predicts vein anatomy and quality leading to improved post-operative leg morbidity. Interactive Cardiovascular and Thoracic Surgery 7. 2008;188-191.

Vazquez, SR, Kahn, SR. Postthrombotic Syndrome. Circulation. 2010;121:e217-e219.

L27506, Non-Invasive Peripheral Venous Studies, Novitas Solutions Jurisdiction L Local Coverage Determination

L34924, Treatment of Varicose Veins and Venous Stasis Disease of the Lower Extremities, Novitas Solutions Jurisdiction H & L Local Coverage Determination

L35448, Independent Diagnostic Testing Facility (IDTF), Novitas Solutions Jurisdiction H & L Local Coverage Determination

A53252 Independent Diagnostic Testing Facility (IDTF), Novitas Solutions Jurisdiction H & L Local Coverage Article

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
12/17/2020 R9

LCD revised and published on 12/17/2020 to update the reference to the treatment of varicose veins with the title of the new LCD ‘Treatment of Chronic Venous Insufficiency of the Lower Extremities’ (L34924) in the ‘Covered Indications’ section, Bullet #2 Chronic Venous Insufficiency in response to the new LCD becoming effective 12/27/2020. Minor formatting changes made throughout.

  • Other (Non-Substantive Change)
10/17/2019 R8

LCD revised and published on 10/17/2019. Consistent with CMS Change Request 10901, the entire coding section has been removed from the LCD and placed into the related Billing and Coding Article, A52993. All CPT codes and coding information within the text of the LCD has been placed in the Billing and Coding Article.The following has been removed from the Documentation Requirements: The submitted medical record must support the use of the selected ICD-10-CM code(s). The submitted CPT/HCPCS code must describe the service performed.

  • Other (CMS Change Request 10901)
03/21/2019 R7

LCD revised and published on 03/21/2019 effective for dates of service on and after 03/21/2019 to remove CMS IOM and NCD language and all codes from the LCD per CMS Change Request (CR) 10901. IOM citation added for IOM language removed per CMS CR 10901and IOM citation for National Correct Coding Initiative (NCCI) removed consistent with the removal of billing and coding information. There has been no change in the content to the LCD.

  • Other (CMS Requirement)
07/12/2018 R6

LCD revised and published on 07/12/2018 to update per LCD annual review.  The IOM references in the “CMS National Coverage Policy” section were updated and the references to the 2016 AMA CPT codebook were updated to the 2018 version. No change was made to coverage content.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy.

  • Other (LCD Annual Review)
10/01/2017 R5

LCD revised and published on 10/05/2017 effective for dates of service on and after 10/01/2017 to reflect the Annual ICD-10-CM Code Updates.

The following ICD-10-CM code(s) have been added to the LCD: Group 1 Code Additions: L97.115, L97.116, L97.118, L97.125, L97.126, L97.128, L97.215, L97.216, L97.218, L97.225, L97.226, L97.228, L97.315, L97.316, L97.318, L97.325, L97.326, L97.328, L97.415, L97.416, L97.418, L97.425, L97.426, L97.428, L97.515, L97.516, L97.518, L97.525, L97.526, L97.528, L97.815, L97.816, L97.818, L97.825, L97.826, and L97.828.

The following ICD-10-CM code(s) have undergone a descriptor change: Group 1 Code Descriptor Revisions: I82.811, I82.812, I83.811, I83.812, I83.891, and I83.892.

At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To ICD-10-CM Code Changes
01/01/2017 R4 LCD revised and published on 01/12/2017 effective for dates of service on and after 01/01/2017 to reflect the annual CPT/HCPCS code updates. The following CPT code has been deleted and therefore removed from this LCD: 93965 has been deleted from the Group 1 codes, indications, limitations and documentation section.
  • Revisions Due To CPT/HCPCS Code Changes
12/01/2016 R3 LCD posted for notice on 10/13/2016. LCD becomes effective for dates of service on and after 12/01/2016.

05/19/2016 DL35451 Draft LCD posted for comment.
  • Aberrant Local Utilization
10/01/2016 R2 LCD revised and published on 09/29/2016 effective for dates of service on and after 10/01/2016 to reflect the ICD-10 Annual Code Updates. The following ICD-10 code(s) have been deleted and therefore removed from the LCD: Group 1 codes T85.81XA, T85.82XA, T85.83XA, T85.84XA, T85.85XA, T85.86XA, and T85.89XA. The following ICD-10 code(s) have undergone a descriptor change: Group 1 codes T82.817A, T82.818A, T82.827A, T82.828A, T82.837A, T82.838A, T82.847A, T82.848A, T82.857A, T82.858A, T82.867A, T82.868A, T83.81XA, T83.82XA, T83.83XA, T83.84XA, T83.85XA, and T83.86XA. The following ICD-10 code(s) have been added to the LCD: Group 1 codes T85.818A, T85.828A, T85.838A, T85.848A, T85.858A, T85.868A, and T85.898A.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R1 LCD revised and published on 12/11/2014 to add Venous Sonographer accredited by the ARRT to the list of examples of appropriate certification in the limitations section of the LCD. Article by Peter Lawrence reviewed and added to sources in response to a reconsideration requesting coverage of follow up duplex scans. No change made to the LCD in response to this reconsideration request as the language in the LCD regarding follow up duplex scans is consistent with the article.
  • Reconsideration Request
N/A

Associated Documents

Attachments
N/A
Public Versions
Updated On Effective Dates Status
12/08/2023 01/28/2024 - N/A Currently in Effect View
12/11/2020 12/17/2020 - 01/27/2024 Superseded You are here
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer